Cartilage and bone extracellular matrix

Current Pharmaceutical Design

Volumn 15, Issue 12, 2009, Pages 1334-1348

  Gentili, Chiara ^a   Cancedda, Ranieri ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Bone; Cartilage; Collagen; Extracellular matrix; Growth factor; Proteoglycan

Indexed keywords

AGGRECAN; AGGRECANASE; BIOMATERIAL; BONE SIALOPROTEIN; CATHEPSIN; COLLAGEN FIBRIL; COLLAGEN TYPE 11; COLLAGEN TYPE 2; COLLAGEN TYPE 3; COLLAGEN TYPE 9; CYSTEINE; FIBROBLAST GROWTH FACTOR; GLYCOPROTEIN; GLYCOSAMINOGLYCAN; HYALURONIC ACID; INTERLEUKIN 1; INTERLEUKIN 6; MATRIX METALLOPROTEINASE; PERLECAN; PROTEOGLYCAN; SCLEROPROTEIN; SERINE; SOMATOMEDIN C; SYNDECAN 3; TRANSFORMING GROWTH FACTOR BETA; VITRONECTIN;

BONE DEVELOPMENT; BONE MATRIX; BONE REGENERATION; BONE REMODELING; BONE TURNOVER; CARTILAGE DEGENERATION; CARTILAGE MATRIX; CELL COMPOSITION; CELL DIFFERENTIATION; CHONDRODYSPLASIA; CYTOKINE PRODUCTION; ENCHONDRAL OSSIFICATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE MUTATION; GENETIC ENGINEERING; HOMEOSTASIS; HUMAN; MARSHALL SYNDROME; MOLECULAR DYNAMICS; MULTIPLE EPIPHYSEAL DYSPLASIA; NONHUMAN; OSTEOARTHRITIS; OSTEOGENESIS IMPERFECTA; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; REVIEW; SIGNAL TRANSDUCTION; TISSUE REGENERATION;

ANIMALS; BONE AND BONES; BONE DEVELOPMENT; BONE DISEASES; CARTILAGE; CARTILAGE DISEASES; EXTRACELLULAR MATRIX; HUMANS;

EID: 65649089459     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161209787846739     Document Type: Review

References (158)

1. Velleman SG. The role of the extracellular matrix in skeletal development. Poult Sci 2000; 79(7): 985-9.
2. Vanhoutte D, Schellings M, Pinto Y, Heymans S. Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window. Cardiovasc Res 2006; 69(3): 604-13.
3. Ostadal B, Kolar F, Pelouch V, Widimsky J. Ontogenetic differences in cardiopulmonary adaptation to chronic hypoxia. Physiol Res 1995; 44(1): 45-51.
4. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980; 284(5751): 67-8.
5. Aigner T, Soeder S, Haag J. IL-1beta and BMPs-interactive players of cartilage matrix degradation and regeneration. Eur Cell Mater 2006; 12: 49-56; discussion
6. Aigner T, McKenna L. Molecular pathology and pathobiology of osteoarthritic cartilage. Cell Mol Life Sci 2002; 59(1): 5-18.
7. Solursh M. Differentiation of cartilage and bone. Curr Opin Cell Biol 1989; 1(5): 989-94.
8. Barna M, Niswander L. Visualization of cartilage formation: insight into cellular properties of skeletal progenitors and chondrodysplasia syndromes. Dev Cell 2007; 12(6): 931-41.
9. Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 2002; 16(21): 2813-28.
10. Sandell LJ, Morris N, Robbins JR, Goldring MB. Alternatively spliced type II procollagen mRNAs define distinct populations of cells during vertebral development: differential expression of the amino-propeptide. J Cell Biol 1991; 114(6): 1307-19.
11. Oberlender SA, Tuan RS. Expression and functional involvement of N-cadherin in embryonic limb chondrogenesis. Development 1994; 120(1): 177-87.
12. Widelitz RB, Jiang TX, Murray BA, Chuong CM. Adhesion molecules in skeletogenesis: II. Neural cell adhesion molecules mediate precartilaginous mesenchymal condensations and enhance chondrogenesis. J Cell Physiol 1993; 156(2): 399-411.
13. Mackie EJ, Thesleff I, Chiquet-Ehrismann R. Tenascin is associated with chondrogenic and osteogenic differentiation in vivo and promotes chondrogenesis in vitro. J Cell Biol 1987; 105(6 Pt 1): 2569-79.
14. Chen FH, Herndon ME, Patel N, Hecht JT, Tuan RS, Lawler J. Interaction of cartilage oligomeric matrix protein/thrombospondin 5 with aggrecan. J Biol Chem 2007; 282(34): 24591-8.
15. Deng C, Wynshaw-Boris A, Zhou F, Kuo A, Leder P. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 1996; 84(6): 911-21.
16. Vortkamp A, Lee K, Lanske B, Segre GV, Kronenberg HM, Tabin CJ. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 1996; 273(5275): 613-22.
17. Yoshida CA, Yamamoto H, Fujita T, Furuichi T, Ito K, Inoue K, et al. Runx2 and Runx3 are essential for chondrocyte maturation, and Runx2 regulates limb growth through induction of Indian hedgehog. Genes Dev 2004; 18(8): 952-63.
18. Gentili C, Bianco P, Neri M, Malpeli M, Campanile G, Castagnola P, et al. Cell proliferation, extracellular matrix mineralization, and ovotransferrin transient expression during in vitro differentiation of chick hypertrophic chondrocytes into osteoblast-like cells. J Cell Biol 1993; 122(3): 703-12.
19. Ducy P, Karsenty G. Genetic control of cell differentiation in the skeleton. Curr Opin Cell Biol 1998; 10(5): 614-9.
20. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999; 5(6): 623-8.
21. Mattot V, Raes MB, Henriet P, Eeckhout Y, Stehelin D, Vandenbunder B, et al. Expression of interstitial collagenase is restricted to skeletal tissue during mouse embryogenesis. J Cell Sci 1995; 108 (Pt 2): 529-35.
22. Adams SL, Cohen AJ, Lassova L. Integration of signaling pathways regulating chondrocyte differentiation during endochondral bone formation. J Cell Physiol 2007; 213(3): 635-41.
23. Blair HC, Teitelbaum SL, Ghiselli R, Gluck S. Osteoclastic bone resorption by a polarized vacuolar proton pump. Science 1989; 245(4920): 855-7.
24. Jimi E, Nakamura I, Amano H, Taguchi Y, Tsurukai T, Tamura M, et al. Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact. Endocrinology 1996; 137(5): 2187-90.
25. Blair HC, Zaidi M, Schlesinger PH. Mechanisms balancing skeletal matrix synthesis and degradation. Biochem J 2002; 364(Pt 2): 329-41.
26. Heinegard D, Oldberg A. Structure and biology of cartilage and bone matrix noncollagenous macromolecules. FASEB J 1989; 3(9): 2042-51.
27. Bruckner P, van der Rest M. Structure and function of cartilage collagens. Microsc Res Tech 1994; 28(5): 378-84.
28. Roughley PJ, Lee ER. Cartilage proteoglycans: structure and potential functions. Microsc Res Tech 1994; 28(5): 385-97.
29. Hagg R, Bruckner P, Hedbom E. Cartilage fibrils of mammals are biochemically heterogeneous: differential distribution of decorin and collagen IX. J Cell Biol 1998; 142(1): 285-94.
30. Poole CA, Flint MH, Beaumont BW. Morphological and functional interrelationships of articular cartilage matrices. J Anat 1984; 138 (Pt 1): 113-38.
31. Mow VC, Wang CC, Hung CT. The extracellular matrix, interstitial fluid and ions as a mechanical signal transducer in articular cartilage. Osteoarthritis Cartilage 1999; 7(1): 41-58.
32. Buckwalter JA, Mankin HJ. Articular cartilage: tissue design and chondrocyte-matrix interactions. Instr Course Lect 1998; 47: 477-86.
33. Kresse H, Schonherr E. Proteoglycans of the extracellular matrix and growth control. J Cell Physiol 2001; 189(3): 266-74.
34. Eyre DR, Brickley-Parsons DM, Glimcher MJ. Predominance of type I collagen at the surface of avian articular cartilage. FEBS Lett 1978; 85(2): 259-63.
35. Kadler KE, Holmes DF, Trotter JA, Chapman JA. Collagen fibril formation. Biochem J 1996; 316 (Pt 1): 1-11.
36. Hoshi K, Ozawa H. [Control of calcification by extracellular matrix]. Clin Calcium 2004; 14(6): 16-22.
37. Alberts B, editor. Cell junctions, cell adhesion, and the extracellular matrix.. New York, NY: Garland Science; 2002.
38. Manton KJ, Leong DF, Cool SM, Nurcombe V. Disruption of heparan and chondroitin sulfate signaling enhances mesenchymal stem cell-derived osteogenic differentiation via bone morphogenetic protein signaling pathways. Stem Cells 2007; 25(11): 2845-54
39. Iozzo RV. Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 1998; 67: 609-52.
40. Jiao X, Billings PC, O'Connell MP, Kaplan FS, Shore EM, Glaser DL. Heparan sulfate proteoglycans (HSPGs) modulate BMP2 osteogenic bioactivity in C2C12 cells. J Biol Chem 2007; 282(2): 1080-6.
41. Bastow ER, Byers S, Golub SB, Clarkin CE, Pitsillides AA, Fosang AJ. Hyaluronan synthesis and degradation in cartilage and bone. Cell Mol Life Sci 2008; 65(3): 395-413.
42. Lisignoli G, Cristino S, Piacentini A, Cavallo C, Caplan AI, Facchini A. Hyaluronan-based polymer scaffold modulates the expression of inflammatory and degradative factors in mesenchymal stem cells: Involvement of Cd44 and Cd54. J Cell Physiol 2006; 207(2): 364-73.
43. Zhou PH, Liu SQ, Peng H. The effect of hyaluronic acid on IL-1beta-induced chondrocyte apoptosis in a rat model of osteoarthritis. J Orthop Res 2008; 26(12): 1643-8.
44. Goldberg VM, Buckwalter JA. Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity. Osteoarthritis Cartilage 2005; 13(3): 216-24.
45. Tognana E, Borrione A, De Luca C, Pavesio A. Hyalograft C: hyaluronan-based scaffolds in tissue-engineered cartilage. Cells Tissues Organs 2007; 186(2): 97-103.
46. Giannoni P, Pagano A, Maggi E, Arbico R, Randazzo N, Grandizio M, et al. Autologous chondrocyte implantation (ACI) for aged patients: development of the proper cell expansion conditions for possible therapeutic applications. Osteoarthritis Cartilage 2005; 13(7): 589-600.
47. Cancedda R, Dozin B, Giannoni P, Quarto R. Tissue engineering and cell therapy of cartilage and bone. Matrix Biol 2003; 22(1): 81-91.
48. Brittberg M. Autologous chondrocyte transplantation. Clin Orthop Relat Res 1999; (367 Suppl): S147-55.
49. Liao E, Yaszemski M, Krebsbach P, Hollister S. Tissue-engineered cartilage constructs using composite hyaluronic acid/collagen I hydrogels and designed poly(propylene fumarate) scaffolds. Tissue Eng 2007; 13(3): 537-50.
50. Iozzo RV, Murdoch AD. Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB J 1996; 10(5): 598-614.
51. Yanagishita M. Function of proteoglycans in the extracellular matrix. Acta Pathol Jpn 1993; 43(6): 283-93.
52. Knudson CB, Knudson W. Cartilage proteoglycans. Semin Cell Dev Biol 2001; 12(2): 69-78.
53. Roughley PJ. The structure and function of cartilage proteoglycans. Eur Cell Mater 2006; 12: 92-101.
54. Jarvelainen HT, Kinsella MG, Wight TN, Sandell LJ. Differential expression of small chondroitin/dermatan sulfate proteoglycans, PG-I/ biglycan and PG-II/decorin, by vascular smooth muscle and endothelial cells in culture. J Biol Chem 1991; 266(34): 23274-81.
55. Dudhia J. Aggrecan, aging and assembly in articular cartilage. Cell Mol Life Sci 2005; 62(19-20): 2241-56.
56. Hedbom E, Heinegard D. Binding of fibromodulin and decorin to separate sites on fibrillar collagens. J Biol Chem 1993; 268(36): 27307-12.
57. Watanabe H, Kimata K, Line S, Strong D, Gao LY, Kozak CA, et al. Mouse cartilage matrix deficiency (cmd) caused by a 7 bp deletion in the aggrecan gene. Nat Genet 1994; 7(2): 154-7.
58. Li H, Schwartz NB, Vertel BM. cDNA cloning of chick cartilage chondroitin sulfate (aggrecan) core protein and identification of a stop codon in the aggrecan gene associated with the chondrodystrophy, nanomelia. J Biol Chem 1993; 268(31): 23504-11.
59. Watanabe H, Yamada Y, Kimata K. Roles of aggrecan, a large chondroitin sulfate proteoglycan, in cartilage structure and function. J Biochem 1998; 124(4): 687-93.
60. Stirpe NS, Argraves WS, Goetinck PF. Chondrocytes from the cartilage proteoglycan-deficient mutant, nanomelia, synthesize greatly reduced levels of the proteoglycan core protein transcript. Dev Biol 1987; 124(1): 77-81.
61. Bernfield M, Kokenyesi R, Kato M, Hinkes MT, Spring J, Gallo RL, et al. Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol 1992; 8: 365-93.
62. Shimazu A, Nah HD, Kirsch T, Koyama E, Leatherman JL, Golden EB, et al. Syndecan-3 and the control of chondrocyte proliferation during endochondral ossification. Exp Cell Res 1996; 229(1): 126-36.
63. Asundi VK, Carey DJ. Self-association of N-syndecan (syndecan-3) core protein is mediated by a novel structural motif in the transmembrane domain and ectodomain flanking region. J Biol Chem 1995; 270(44): 26404-10.
64. Chernousov MA, Carey DJ. N-syndecan (syndecan 3) from neonatal rat brain binds basic fibroblast growth factor. J Biol Chem 1993; 268(22): 16810-4.
65. Reiland J, Sanderson RD, Waguespack M, Barker SA, Long R, Carson DD, et al. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion. J Biol Chem 2004; 279(9): 8047-55.
66. Shimo T, Gentili C, Iwamoto M, Wu C, Koyama E, Pacifici M. Indian hedgehog and syndecans-3 coregulate chondrocyte proliferation and function during chick limb skeletogenesis. Dev Dyn 2004; 229(3): 607-17.
67. Pacifici M, Shimo T, Gentili C, Kirsch T, Freeman TA, Enomoto-Iwamoto M, et al. Syndecan-3: a cell-surface heparan sulfate proteoglycan important for chondrocyte proliferation and function during limb skeletogenesis. J Bone Miner Metab 2005; 23(3): 191-9.
68. Kirsch T, Koyama E, Liu M, Golub EE, Pacifici M. Syndecan-3 is a selective regulator of chondrocyte proliferation. J Biol Chem 2002; 277(44): 42171-7.
69. Hecht JT, Hogue D, Strong LC, Hansen MF, Blanton SH, Wagner M. Hereditary multiple exostosis and chondrosarcoma: linkage to chromosome II and loss of heterozygosity for EXT-linked markers on chromosomes II and 8. Am J Hum Genet 1995; 56(5): 1125-31.
70. McCormick C, Duncan G, Goutsos KT, Tufaro F. The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate. Proc Natl Acad Sci USA 2000; 97(2): 668-73.
71. Lamoureux F, Baud'huin M, Duplomb L, Heymann D, Redini F. Proteoglycans: key partners in bone cell biology. Bioessays 2007; 29(8): 758-71.
72. Ruoslahti E, Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell 1991; 64(5): 867-9.
73. Iozzo RV. The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit Rev Biochem Mol Biol 1997; 32(2): 141-74.
74. Poole AR, Webber C, Pidoux I, Choi H, Rosenberg LC. Localization of a dermatan sulfate proteoglycan (DS-PGII) in cartilage and the presence of an immunologically related species in other tissues. J Histochem Cytochem 1986; 34(5): 619-25.
75. Couchman JR, Kapoor R, Sthanam M, Wu RR. Perlecan and basement membrane-chondroitin sulfate proteoglycan (bamacan) are two basement membrane chondroitin/dermatan sulfate proteoglycans in the Engelbreth-Holm-Swarm tumor matrix. J Biol Chem 1996; 271(16): 9595-602.
76. Costell M, Gustafsson E, Aszodi A, Morgelin M, Bloch W, Hunziker E, et al. Perlecan maintains the integrity of cartilage and some basement membranes. J Cell Biol 1999; 147(5): 1109-22.
77. Arikawa-Hirasawa E, Watanabe H, Takami H, Hassell JR, Yamada Y. Perlecan is essential for cartilage and cephalic development. Nat Genet 1999; 23(3): 354-8.
78. Brown JC, Sasaki T, Gohring W, Yamada Y, Timpl R. The Cterminal domain V of perlecan promotes beta1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans. Eur J Biochem 1997; 250(1): 39-46.
79. Joseph SJ, Ford MD, Barth C, Portbury S, Bartlett PF, Nurcombe V, et al. A proteoglycan that activates fibroblast growth factors during early neuronal development is a perlecan variant. Development 1996; 122(11): 3443-52.
80. Aviezer D, Hecht D, Safran M, Eisinger M, David G, Yayon A. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell 1994; 79(6): 1005-13.
81. Mongiat M, Fu J, Oldershaw R, Greenhalgh R, Gown AM, Iozzo RV. Perlecan protein core interacts with extracellular matrix protein 1 (ECM1), a glycoprotein involved in bone formation and angiogenesis. J Biol Chem 2003; 278(19): 17491-9.
82. Mathieu E, Meheus L, Raymackers J, Merregaert J. Characterization of the osteogenic stromal cell line MN7: identification of secreted MN7 proteins using two-dimensional polyacrylamide gel electrophoresis, western blotting, and microsequencing. J Bone Miner Res 1994; 9(6): 903-13.
83. Deckers MM, Smits P, Karperien M, Ni J, Tylzanowski P, Feng P, et al. Recombinant human extracellular matrix protein 1 inhibits alkaline phosphatase activity and mineralization of mouse embryonic metatarsals in vitro. Bone 2001; 28(1): 14-20.
84. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1(1): 27-31.
85. Arikawa-Hirasawa E, Wilcox WR, Le AH, Silverman N, Govindraj P, Hassell JR, et al. Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene. Nat Genet 2001; 27(4): 431-4.
86. Bi Y, Stuelten CH, Kilts T, Wadhwa S, Iozzo RV, Robey PG, et al. Extracellular matrix proteoglycans control the fate of bone marrow stromal cells. J Biol Chem 2005; 280(34): 30481-9.
87. Kolacna L, Bakesova J, Varga F, Kostakova E, Planka L, Necas A, et al. Biochemical and biophysical aspects of collagen nanostructure in the extracellular matrix. Physiol Res 2007; 56(Suppl 1): S51-60.
88. Kadler KE, Hill A, Canty-Laird EG. Collagen fibrillogenesis: fibronectin, integrins, and minor collagens as organizers and nucleators. Curr Opin Cell Biol 2008; 20(5): 495-501.
89. Matthews JA, Wnek GE, Simpson DG, Bowlin GL. Electrospinning of collagen nanofibers. Biomacromolecules 2002; 3(2): 232-8.
90. Eyre D. Collagen of articular cartilage. Arthritis Res 2002; 4(1): 30-5.
91. Lane JM, Weiss C. Review of articular cartilage collagen research. Arthritis Rheum 1975; 18(6): 553-62.
92. Chen MH, Broom N. On the ultrastructure of softened cartilage: a possible model for structural transformation. J Anat 1998; 192 (Pt 3): 329-41.
93. Shaw LM, Olsen BR. FACIT collagens: diverse molecular bridges in extracellular matrices. Trends Biochem Sci 1991; 16(5): 191-4.
94. van der Rest M, Mayne R. Type IX collagen proteoglycan from cartilage is covalently cross-linked to type II collagen. J Biol Chem 1988; 263(4): 1615-8.
95. Fassler R, Schnegelsberg PN, Dausman J, Shinya T, Muragaki Y, McCarthy MT, et al. Mice lacking alpha 1 (IX) collagen develop noninflammatory degenerative joint disease. Proc Natl Acad Sci USA 1994; 91(11): 5070-4.
96. Briggs MD, Choi H, Warman ML, Loughlin JA, Wordsworth P, Sykes BC, et al. Genetic mapping of a locus for multiple epiphyseal dysplasia (EDM2) to a region of chromosome 1 containing a type IX collagen gene. Am J Hum Genet. 1994 Oct; 55(4): 678-84.
97. Wotton SF, Duance VC. Type III collagen in normal human articular cartilage. Histochem J 1994; 26(5): 412-6.
98. Aigner T, Bertling W, Stoss H, Weseloh G, von der Mark K. Independent expression of fibril-forming collagens I, II, and III in chondrocytes of human osteoarthritic cartilage. J Clin Invest 1993; 91(3): 829-37.
99. Pace JM, Corrado M, Missero C, Byers PH. Identification, characterization and expression analysis of a new fibrillar collagen gene, COL27A1. Matrix Biol 2003; 22(1): 3-14.
100. Quarto R, Dozin B, Bonaldo P, Cancedda R, Colombatti A. Type VI collagen expression is upregulated in the early events of chondrocyte differentiation. Development 1993; 117(1): 245-51.
101. Pullig O, Weseloh G, Swoboda B. Expression of type VI collagen in normal and osteoarthritic human cartilage. Osteoarthritis Cartilage 1999; 7(2): 191-202.
102. Kassner A, Hansen U, Miosge N, Reinhardt DP, Aigner T, Bruckner-Tuderman L, et al. Discrete integration of collagen XVI into tissue-specific collagen fibrils or beaded microfibrils. Matrix Biol 2003; 22(2): 131-43.
103. Watt SL, Lunstrum GP, McDonough AM, Keene DR, Burgeson RE, Morris NP. Characterization of collagen types XII and XIV from fetal bovine cartilage. J Biol Chem 1992; 267(28): 20093-9.
104. Castagnola P, Tavella S, Gerecke DR, Dublet B, Gordon MK, Seyer J, et al. Tissue-specific expression of type XIV collagen - a member of the FACIT class of collagens. Eur J Cell Biol 1992; 59(2): 340-7.
105. Eyre DR, Wu JJ, Apone S. A growing family of collagens in articular cartilage: identification of 5 genetically distinct types. J Rheumatol. 1987 May; 14 Spec No: 25-7.
106. Gannon JM, Walker G, Fischer M, Carpenter R, Thompson RC, Jr., Oegema TR, Jr. Localization of type X collagen in canine growth plate and adult canine articular cartilage. J Orthop Res 1991; 9(4): 485-94.
107. Cancedda R, Capasso O, Castagnola P, Descalzi-Cancedda F, Quarto N. Deposition of type X collagen in the cartilage extracellular matrix. J Cell Biochem 1985; 28(1): 7-14.
108. Carlevaro MF, Cermelli S, Cancedda R, Descalzi Cancedda F. Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. J Cell Sci 2000; 113 (Pt 1): 59-69.
109. Descalzi Cancedda F, Gentili C, Manduca P, Cancedda R. Hypertrophic chondrocytes undergo further differentiation in culture. J Cell Biol 1992; 117(2): 427-35.
110. Carlevaro MF, Albini A, Ribatti D, Gentili C, Benelli R, Cermelli S, et al. Transferrin promotes endothelial cell migration and invasion: implication in cartilage neovascularization. J Cell Biol 1997; 136(6): 1375-84.
111. Riminucci M, Bradbeer JN, Corsi A, Gentili C, Descalzi F, Cancedda R, et al. Vis-a-vis cells and the priming of bone formation. J Bone Miner Res. 1998 Dec; 13(12): 1852-61.
112. Vashishth D. The role of the collagen matrix in skeletal fragility. Curr Osteoporos Rep 2007; 5(2): 62-6.
113. Kamoun-Goldrat AS, Le Merrer MF. Animal models of osteogenesis imperfecta and related syndromes. J Bone Miner Metab 2007; 25(4): 211-8.
114. Myllyharju J, Kivirikko KI. Collagens and collagen-related diseases. Ann Med 2001 Feb; 33(1): 7-21.
115. Unger SL, Briggs MD, Holden P, Zabel B, Ala-Kokko L, Paassilta P, et al. Multiple epiphyseal dysplasia: radiographic abnormalities correlated with genotype. Pediatr Radiol 2001; 31(1): 10-8.
116. Griffith AJ, Sprunger LK, Sirko-Osadsa DA, Tiller GE, Meisler MH, Warman ML. Marshall syndrome associated with a splicing defect at the COL11A1 locus. Am J Hum Genet 1998; 62(4): 816-23.
117. Goldring MB. The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models. Connect Tissue Res 1999; 40(1): 1-11.
118. Guerne PA, Sublet A, Lotz M. Growth factor responsiveness of human articular chondrocytes: distinct profiles in primary chondrocytes, subcultured chondrocytes, and fibroblasts. J Cell Physiol 1994; 158(3): 476-84.
119. Moos V, Fickert S, Muller B, Weber U, Sieper J. Immunohistological analysis of cytokine expression in human osteoarthritic and healthy cartilage. J Rheumatol 1999; 26(4): 870-9.
120. Mundy GR. Cytokines and local factors which affect osteoclast function. Int J Cell Cloning 1992; 10(4): 215-22.
121. Westacott CI, Sharif M. Cytokines in osteoarthritis: mediators or markers of joint destruction? Semin Arthritis Rheum 1996; 25(4): 254-72.
122. Olney RC, Wilson DM, Mohtai M, Fielder PJ, Smith RL. Interleukin-1 and tumor necrosis factor-alpha increase insulin-like growth factor-binding protein-3 (IGFBP-3) production and IGFBP-3 protease activity in human articular chondrocytes. J Endocrinol 1995; 146(2): 279-86.
123. Verschure PJ, van Marle J, Joosten LA, van den Berg WB. Chondrocyte IGF-1 receptor expression and responsiveness to IGF-1 stimulation in mouse articular cartilage during various phases of experimentally induced arthritis. Ann Rheum Dis 1995; 54(8): 645-53.
124. van den Berg WB. Uncoupling of inflammatory and destructive mechanisms in arthritis. Semin Arthritis Rheum 2001; 30(5 Suppl 2): 7-16.
125. Fiore MM. Cellular specificity for the activation of fibroblast growth factor-2 by heparan sulfate proteoglycan. Biochem Biophys Res Commun 2001; 284(2): 384-8.
126. Yanagishita M. [Regulation of cell proliferation by proteoglycans]. Tanpakushitsu Kakusan Koso 1998; 43(16 Suppl): 2589-93.
127. Chambers MG, Bayliss MT, Mason RM. Chondrocyte cytokine and growth factor expression in murine osteoarthritis. Osteoarthritis Cartilage 1997; 5(5): 301-8.
128. Cermelli S, Zerega B, Carlevaro M, Gentili C, Thorp B, Farquharson C, et al. Extracellular fatty acid binding protein (Ex-FABP) modulation by inflammatory agents: "physiological" acute phase response in endochondral bone formation. Eur J Cell Biol 2000; 79(3): 155-64.
129. Gentili C, Tutolo G, Pianezzi A, Cancedda R, Descalzi Cancedda F. Cholesterol secretion and homeostasis in chondrocytes: a liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein A1 expression. Matrix Biol 2005; 24(1): 35-44.
130. Descalzi Cancedda F, Melchiori A, Benelli R, Gentili C, Masiello L, Campanile G, et al. Production of angiogenesis inhibitors and stimulators is modulated by cultured growth plate chondrocytes during in vitro differentiation: dependence on extracellular matrix assembly. Eur J Cell Biol 1995; 66(1): 60-8.
131. Ho ML, Chang JK, Wang GJ. Effects of ketorolac on bone repair: A radiographic study in modeled demineralized bone matrix grafted rabbits. Pharmacology 1998; 57(3): 148-59.
132. Arikawa T, Omura K, Morita I. Regulation of bone morphogenetic protein-2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells. J Cell Physiol 2004; 200(3): 400-6.
133. Blain EJ. Mechanical regulation of matrix metalloproteinases. Front Biosci 2007; 12: 507-27.
134. Ra HJ, Parks WC. Control of matrix metalloproteinase catalytic activity. Matrix Biol 2007; 26(8): 587-96.
135. Krane SM, Inada M. Matrix metalloproteinases and bone. Bone 2008; 43(1): 7-18.
136. Varghese S. Matrix metalloproteinases and their inhibitors in bone: an overview of regulation and functions. Front Biosci 2006; 11: 2949-66.
137. Ortega N, Behonick DJ, Werb Z. Matrix remodeling during endochondral ossification. Trends Cell Biol 2004; 14(2): 86-93.
138. Hardingham T. Extracellular matrix and pathogenic mechanisms in osteoarthritis. Curr Rheumatol Rep 2008; 10(1): 30-6.
139. Martel-Pelletier J, Boileau C, Pelletier JP, Roughley PJ. Cartilage in normal and osteoarthritis conditions. Best Pract Res Clin Rheumatol 2008; 22(2): 351-84.
140. Chen AC, Temple MM, Ng DM, Verzijl N, DeGroot J, TeKoppele JM, et al. Induction of advanced glycation end products and alterations of the tensile properties of articular cartilage. Arthritis Rheum 2002; 46(12): 3212-7.
141. Bank RA, Soudry M, Maroudas A, Mizrahi J, TeKoppele JM. The increased swelling and instantaneous deformation of osteoarthritic cartilage is highly correlated with collagen degradation. Arthritis Rheum 2000; 43(10): 2202-10.
142. Wu W, Billinghurst RC, Pidoux I, Antoniou J, Zukor D, Tanzer M, et al. Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13. Arthritis Rheum 2002; 46(8): 2087-94.
143. Yasuda T. Cartilage destruction by matrix degradation products. Mod Rheumatol 2006; 16(4): 197-205.
144. Fosang AJ, Rogerson FM, East CJ, Stanton H. ADAMTS-5: the story so far. Eur Cell Mater 2008; 15: 11-26.
145. Goldring MB, Goldring SR. Osteoarthritis. J Cell Physiol 2007; 213(3): 626-34.
146. Lai JY, Chang PY, Lin JN. Body wall repair using small intestinal submucosa seeded with cells. J Pediatr Surg 2003; 38(12): 1752-5.
147. Mantovani F, Trinchieri A, Castelnuovo C, Romano AL, Pisani E. Reconstructive urethroplasty using porcine acellular matrix. Eur Urol 2003; 44(5): 600-2.
148. Lopes MF, Cabrita A, Ilharco J, Pessa P, Paiva-Carvalho J, Pires A, et al. Esophageal replacement in rat using porcine intestinal submucosa as a patch or a tube-shaped graft. Dis Esophagus 2006; 19(4): 254-9.
149. Demling RH. The clinical relevance of defining the mechanism for altered gut permeability in a "two-hit" model of injury and infection. Crit Care Med 2004; 32(11): 2356-7.
150. Quarto R, Mastrogiacomo M, Cancedda R, Kutepov SM, Mukhachev V, Lavroukov A, et al. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 2001; 344(5): 385-6.
151. Yannas IV, Lee E, Orgill DP, Skrabut EM, Murphy GF. Synthesis and characterization of a model extracellular matrix that induces partial regeneration of adult mammalian skin. Proc Natl Acad Sci USA 1989; 86(3): 933-7.
152. Patino MG, Neiders ME, Andreana S, Noble B, Cohen RE. Collagen as an implantable material in medicine and dentistry. J Oral Implantol 2002; 28(5): 220-5.
153. Zhang S. Fabrication of novel biomaterials through molecular self-assembly. Nat Biotechnol 2003; 21(10): 1171-8.
154. Kisiday J, Jin M, Kurz B, Hung H, Semino C, Zhang S, et al. Self-assembling peptide hydrogel fosters chondrocyte extracellular matrix production and cell division: implications for cartilage tissue repair. Proc Natl Acad Sci USA 2002; 99(15): 9996-10001.
155. Peppas NA, Bures P, Leobandung W, Ichikawa H. Hydrogels in pharmaceutical formulations. Eur J Pharm Biopharm 2000; 50(1): 27-46.
156. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 1996; 12: 697-715.
157. Lutolf MP, Hubbell JA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 2005; 23(1): 47-55.
158. Muraglia A, Corsi A, Riminucci M, Mastrogiacomo M, Cancedda R, Bianco P, et al. Formation of a chondro-osseous rudiment in micromass cultures of human bone-marrow stromal cells. J Cell Sci 2003; 116(Pt 14): 2949-55.